Standex International (ticker: NYSE:SXI), a diversified manufacturing company, reported a decrease in sales but achieved record profit and cash generation in fiscal 2024. The company also expanded its gross and operating margins while investing in research and development to fuel future growth.
Standex plans to introduce a significant number of new products in fiscal 2025, with sales in fast-growth markets projected to surpass $110 million. The company remains confident in its long-term financial outlook, expecting high single-digit organic growth and robust margins by fiscal year 2028.
Key Takeaways
- Standex International reported a decrease in sales but reached record profit and cash generation for fiscal 2024.
- Gross margin and operating margin expanded, with investments in research and development for future growth.
- The company plans to launch a record number of new products in fiscal 2025.
- Sales in fast-growth markets are expected to exceed $110 million.
- Standex reaffirmed their long-term financial outlook for fiscal year 2028, targeting high single-digit organic growth and improved profitability metrics.
Company Outlook
- Standex expects moderately higher revenue and operating margin in the next quarter.
- Long-term financial targets by fiscal year 2028 include high single-digit organic growth, an adjusted operating margin over 19%, a return on invested capital over 15%, and free cash flow conversion around 100% of GAAP net income.
Bearish Highlights
- Scientific revenue dropped by 4.1% to $17.5 million due to decreased demand from retail pharmacies.
- The Specialty Solutions segment saw revenue fall by 6.3% to $24.2 million, primarily due to lower demand in the display merchandising business.
Bullish Highlights
- The Engineering Technologies segment experienced a 15.7% increase in revenue to $25.3 million, propelled by organic growth and higher demand in the aviation end market.
- Operating margins in various segments improved due to productivity initiatives and lower freight costs.
Misses
- Some new products may not succeed despite the company's portfolio strategy aiming to drive top-line growth.
Q&A Highlights
- Executives discussed the growth potential of new products, with sales expected to increase by at least 100 basis points in the coming year.
- The company did not provide specific details about the size of opportunities for new products during the call.
- Optimism was expressed regarding the Electronics segment's margin improvement throughout fiscal year 2025.
Standex International (SXI) concluded its fiscal fourth quarter with $347 million in available liquidity and a net cash position of $5.3 million. The company declared its 240th consecutive cash dividend, marking a 7.1% increase from the previous year. For fiscal year 2025, capital expenditures are projected to be between $35 million and $40 million. With a strong balance sheet, Standex is poised to assess both organic and inorganic growth opportunities for future expansion. Market conditions are expected to stabilize in the first half of fiscal year 2025 and strengthen afterward. The company's executives, David Dunbar and Ademir Sarcevic, expressed optimism for the video electronics segment, which saw a 30% increase in June with continued growth in July, and acknowledged challenges in the North American engraving business due to the auto industry's transitional period. Standex's strategy includes a pipeline of over a dozen new products, aiming for higher margins and incremental gross margin impact. The next earnings call is anticipated for the fiscal first quarter of 2025, where the company expects to share more information on specific market opportunities and releases.
InvestingPro Insights
Standex International's (SXI) fiscal 2024 performance, characterized by record profit despite a sales decrease, reflects a company that is managing to improve its financial health in challenging times. With a focus on expanding gross and operating margins, the company's strategic investments in research and development are aimed at driving future growth.
InvestingPro Data shows that Standex International has a market capitalization of $2.11 billion, with a Price/Earnings (P/E) ratio of 28.82, which adjusts to 25.81 when looking at the last twelve months as of Q4 2024. The company's Gross Profit Margin stands at a healthy 39.13% for the same period, which aligns with the company's reported margin expansion. Standex's operating income margin was also solid at 15.58% during the last twelve months as of Q4 2024.
Among the InvestingPro Tips, Standex's ability to raise its dividend for 13 consecutive years, coupled with maintaining dividend payments for 54 consecutive years, signals a strong commitment to shareholder returns. This is particularly noteworthy as the company has also managed a strong return over the last month, with a 13.16% price total return, and an impressive return over the last five years. These returns are indicative of the company's robust financial performance and its ability to generate value for investors over time.
For investors looking for further insights and tips on Standex International, there are additional InvestingPro Tips available at: https://www.investing.com/pro/SXI. These tips can provide a deeper understanding of the company's financial health and future prospects.
Full transcript - Standex International Corp (SXI) Q4 2024:
Operator: Good morning, ladies and gentlemen, and welcome to the Standex International Fiscal Fourth Quarter 2024 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Friday, August 2, 2024. I would now like to turn the conference over to Chris Howe, Director of Investor Relations. Please go ahead.
Christopher Howe: Thank you, operator, and good morning. Please note that the presentation accompanying management's remarks can be found on the Investor Relations portion of the company's website at www.standex.com. Please refer to Standex' safe harbor statement on Slide 2. Matters that Standex management will discuss on today's conference call include predictions, estimates, expectations and other forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially. You should refer to Standex' most recent annual report on Form 10-K as well as other SEC filings and public announcements for a detailed list of risk factors. In addition, I'd like to remind you that today's discussion will include references to the non-GAAP measures of EBIT, which is earnings before interest and taxes; adjusted EBIT, which is EBIT, excluding restructuring, purchase accounting, acquisition-related expenses and onetime items; EBITDA, which is earnings before interest, taxes, depreciation and amortization; adjusted EBITDA, which is EBITDA excluding restructuring, purchase accounting, acquisition-related expenses and onetime items; EBITDA margin and adjusted EBITDA margin. We will also refer to other non-GAAP measures, including adjusted net income, adjusted operating income, adjusted net income from continuing operations, adjusted earnings per share, adjusted operating margin, free operating cash flow and pro forma net debt to EBITDA. These non-GAAP financial measures are intended to serve as a complement to results provided in accordance with accounting principles generally accepted in the United States. Standex believes that such information provides an additional measurement and consistent historical comparison of the company's financial performance. On the call today is Standex' Chairman, President and Chief Executive Officer, David Dunbar; and Chief Financial Officer and Treasurer, Ademir Sarcevic.
David Dunbar: Thank you, Chris. Good morning, and welcome to our fiscal fourth quarter and fiscal year 2024 conference call. I would like to thank our corporate finance team and each of our business leaders for achieving our record profit and cash generation in fiscal 2024 with challenging general market conditions pressuring the top line. Behind the scenes, our engineering and sales and marketing teams continued to ramp up new product development and enhance our competitive position. As a result, in fiscal 2024, we expanded gross margin 90 basis points and operating margin 60 basis points while investing an additional $3.3 million in research and development to fuel our future growth initiatives. Even in the face of challenging market conditions, we continue to expand margins and increase investments for future growth. In fiscal 2025, we expect to release a record number of new products. Now if everyone can turn to Slide 3, key messages. In the fourth quarter, sales declined 4.3% with contributions from acquisitions and fast-growth markets, partially offsetting an organic decline. Though sales were down in Electronics due to continued soft demand in appliances and general industrial end markets in China and Europe, we have seen orders strengthening these past two months indicating that markets are improving and that our commercial strategy is taking hold. We also experienced an impact from a slowdown of new vehicle introductions in North America affecting our Engraving segment. We expect demand to improve as we enter the second half of fiscal 2025. Demand in Asia and Europe remained stable. Sales in the fast-growth end markets grew 13% year-on-year to $27 million in the fourth quarter and grew 13% year-on-year to $94 million in fiscal 2024. Sales grew faster than expected in space and defense end markets and slower than expected in renewable energy, electric vehicles and smart grid applications. I am especially pleased that we continue to demonstrate resilient operating performance from the execution of our price and productivity initiatives. As a result, we achieved adjusted operating margin of 16%, up 60 basis points on a sequential basis. Four of our five segments reported adjusted operating margin above 20%. Following record profitability in fiscal 2023, we again achieved fiscal year record milestones in adjusted gross margin, adjusted operating income, adjusted operating margin, adjusted earnings per share and free cash flow. At the same time, in fiscal year 2024, research and development investments were the highest ever and increased $3.3 million to 2.8% of sales. We remain optimistic about our long-term operating margin potential as we leverage better general market conditions and a higher sales contribution from new products and new applications. On a sequential basis, in fiscal first quarter 2025 we expect similar to slightly higher revenue as higher sales into fast-growth end-markets are mostly offset by less favorable project timing in the Engineering Technologies segment. We expect similar to slightly higher gross margin and slightly lower to similar adjusted operating margin due to higher investments in selling, marketing and R&D. We are positioned to release new products in every business in fiscal 2025, contributing over 100 basis points of incremental growth. I will go into more detail on the next slide. In addition, we anticipate fast-growth market sales to grow above 20% and exceed $110 million in fiscal 2025. In fiscal year 2025, we expect general market conditions to stabilize in the first half and strengthen as we move further into the second half, providing a healthier backdrop of growth. We are reaffirming our long-term financial outlook by fiscal year 2028. These targets include high single-digit organic growth to greater than $1 billion in sales, adjusted operating margin greater than 19%, return on invested capital of greater than 15% and free cash flow conversion at approximately 100% of GAAP net income. Let's turn to Slide 4 that highlights our progress -- once ahead for new product development and new applications. Personally, I'm very excited about 2025. This slide has literally been 10 years in the making. We began ramping up our R&D spending about five years ago as we completed our portfolio transformation and began focusing on operational improvements. As our margins and our predictability improved, we were able to increase our R&D spending as you see in the graph here, growing from $6.3 million to $20.5 million. A new product development can take several years, then must be incorporated into our customers' own new product design cycle, so it takes a few years to convert a new product development project to sales. It's like turning on the spigot in the hose and waiting for the water to come out the other end. Our work is now beginning to bear fruit. New product releases begin with a trickle in 2023 with two new products, followed by three in 2024. Now new products are nearing completion in all businesses, and we anticipate releasing more than 12 new products in 2025. We anticipate they will add more than 1% to our sales growth in 2025. Every business will launch at least one new product, and we will release at least one in every quarter of the year. As the year progresses, we will provide updates on recently released products. This is the year to watch us as we develop the skill to launch new products and ramp their sales. I will now turn the call over to Ademir and discuss our financial performance in greater detail.
Ademir Sarcevic: Thank you, David, and good morning, everyone. Let's turn to Slide 5, fourth quarter 2024 summary. On a consolidated basis, total revenue decreased approximately 4.3% year-on-year to $180.2 million. This reflected an organic revenue decline of 9.4% and 1.1% impact for foreign exchange partially offset by 6.2% benefit from recent acquisitions. Fourth quarter 2024 adjusted operating margin increased 60 basis points year-on-year to 16%. In the fiscal fourth quarter, adjusted operating income decreased 1% on 4.3% consolidated revenue decrease year-on-year. Adjusted earnings per share remained flat year-on-year at $1.76. Net cash provided by operating activities was $28.7 million in the fourth quarter of fiscal 2024 compared to $40.4 million a year ago. Capital expenditures were $6.5 million compared to $7.6 million a year ago. As a result, we generated fiscal fourth quarter free cash flow of $22.2 million compared to $32.8 million a year ago. Our free cash flow conversion ratio as a percent of GAAP net income was 112%. Now please turn to Slide 6, and I will begin to discuss our segment performance and outlook, beginning with Electronics. Segment revenue of $80.4 million increased 0.6% year-on-year as 14.6% benefit from recent acquisitions was mostly offset by an organic decline of 12.3% and 1.6% impact of foreign currency. Adjusted operating margin of 20.5% in fiscal fourth quarter 2024 decreased 50 basis points year-on-year as the contribution from recent acquisitions and pricing and productivity initiatives were more than offset by lower volume. Our new business opportunity funnel increased approximately 30% year-on-year and is currently at approximately $85 million. As David highlighted in his comments, we are starting to see encouraging signs that markets are starting to recover, which is further supported by positive order trends in the last two months. June orders in Electronics increased approximately 30% over the average order intake for the past six months and our July orders increased approximately 5% over June orders. The recent upward trend in monthly orders has been driven by the following factors. Inventory normalization, strengthening of the North American mail aero market, the return of certain semiconductor customers, increased demand for bay reed switches and our commercial focus on gaining share in fast-growth end markets. We anticipate the positive impact from this trend to more meaningfully show in our top line as we move to the second half of our fiscal year. Sequentially, in fiscal first quarter 2025, we expect similar to slightly higher revenue driven by higher sales into fast-growth end markets and similar adjusted operating margin as pricing and productivity initiatives offset higher investment in selling, marketing and R&D. Please turn to Slide 7 for a discussion of the Engraving and Scientific segments. Engraving revenue decreased 22.8% to $32.7 million, driven by organic decline of 21% and 1.9% impact of foreign exchange. Operating margin of 12% in fiscal fourth quarter 2024 decreased 660 basis points year-on-year due to slower demand in North America due to OEM platform push outs. In our next fiscal quarter, on a sequential basis, we expect moderately higher revenue and operating margin due to more favorable project timing in Europe and Asia. Scientific revenue decreased 4.1% to $17.5 million due to lower demand from retail pharmacies. Operating margin of 28.1% increased 260 basis points year-on-year due to impact of productivity initiatives and lower freight costs, partially offset by lower volume. Sequentially, we expect similar revenue and slightly lower operating margin due to continued investments in research and development activities and higher freight costs. Now turn to Slide 8 for a discussion of the Engineering Technologies and Specialty Solutions segments. Engineering Technologies revenue increased 15.7% to $25.3 million, driven by organic growth of 15.9%, slightly offset by 0.2% impact from foreign currency. This strong organic growth was due to higher demand in aviation end market, more favorable project timing and growth in new applications. Operating margin of 20.9% increased 670 basis points year-on-year as leverage on higher sales and productivity initiatives were partially offset by investments in research and development. This represents the fifth consecutive quarter of sequential operating margin improvement in this segment. Sequentially, we expect moderately to significantly lower revenue and slightly lower operating margin due to unfavorable project timing. Specialty Solutions segment revenue of $24.2 million decreased 6.3% year-on-year, primarily due to lower demand in the display merchandising business, partially offset by organic growth in the Hydraulics business. Operating margin of 22.2% decreased 260 basis points year-on-year. Sequentially, we expect similar revenue and operating margin. Next, please turn to Slide 9 for a summary of Standex's liquidity statistics and the capitalization structure, which remains strong. Standex ended fiscal fourth quarter 2024 with $347 million of available liquidity. At the end of the fourth quarter, Standex had net cash of $5.3 million compared to net debt of $10 million at the end of fiscal third quarter 2024. Standex' long-term debt at the end of fiscal fourth quarter 2024 was $148.9 million. Cash and cash equivalents totaled $154.2 million. We declared our 240th quarterly consecutive cash dividend of $0.30 per share and approximately 7.1% increase year-on-year. In fiscal 2025, we expect capital expenditures to be between $35 million and $40 million. I will now turn the call over to David to discuss our key takeaways from our fourth quarter results.
David Dunbar: Thank you, Ademir. Please turn to Slide 10. I'm very proud of our team for their continued operational execution and focus on growing markets that led to our record cash and profit generation in fiscal 2024. We achieved several records that were driven by our operational execution, continued progress of our growth efforts and the successful integration of our recent acquisitions. We remain optimistic about the long-term secular trends that will benefit from the transition from internal combustion to hybrid and electric in automotive; infrastructure spending in smart grid; defense applications and next-generation aerospace development; and from the evolution of space exploration. We anticipate sales into fast-growth end markets to accelerate over our long-term target horizon and beyond as these trends develop. To support our future growth, we continue to invest in our engineering capabilities to drive new product development and new applications across markets with growth potential. In fiscal year 2025, for the first time in the company's history, new products will be released in every one of our businesses. We continue to maintain a strong balance sheet that allows us to prudently assess an active pipeline of organic and inorganic growth opportunities to support future growth. In fiscal 2025, we expect the general market conditions to stabilize in the first half and strengthen as we move further into the second half, barring any unforeseen economic disruptions. We reaffirm our long-term financial outlook by fiscal year 2028. These targets include high single-digit organic growth to greater than $1 billion in sales, adjusted operating margin greater than 19%, return on invested capital of greater than 15% and free cash flow conversion at approximately 100% of GAAP net income. We will now open the line for questions.
Operator: [Operator Instructions] Your first question comes from the line of Michael Legg from Benchmark. Michael, please go ahead.
Michael Legg: Thank you. Good morning, everyone and congratulations on another nice quarter. I wanted to kind of dig into a little bit on the new product development. Can you explain a little bit of the development phase alongside the customer and how you work with them to come up with a new products, whether the next-generation products or new products? And then as they work into the production cycle of the customer, the first year, you gave us 100 basis points improvement. But what does that really mean the second and third year as these things start to be rolled into it? And then just a follow-up on that would be, you have 12 that you've mentioned for fiscal '25. What does the R&D pipe look like longer term for new products? Thanks.
David Dunbar: That's a lot of questions. If I forget any, let me know. So first of all, how we work with customers. As you know, most of our businesses compete on what we call customer intimacy. So our new product ideas come from our customers. We identify applications or neighboring needs of the applications we serve that we don't meet with current product that goes into our innovation hopper and then if it gets through our filters, it goes into new product development. So the ideas come from customers. And in some businesses, like Engineering Technologies, the new product development is actually often funded by the customer and is for a specific customer products. So we don't develop a product simply based on some abstract notion of what the market might need and then launch a new product in the market to see what will happen. We already know customers need it. We work out the specs and the requirements with customers. So when we launch it, we know that we're on the mark. What was the next question, Ademir? You can help me.
Michael Legg: Year two and three, what -- first year, 100 basis points...
David Dunbar: Yes, so this is the year we've said you watch us as we learn how these -- how new products ramp. In general, it takes -- it will take about three years, at least for a new product to ramp to full volume because our customers have to design it into their cycle. And I guess, as the year goes on, we'll make more what our expectations are. I would tell you, we set 100 basis point -- greater than 100 basis point sales from new products this year. We certainly have internal targets higher than that. As we get more customer wins, we'll be able to portray better evolution in years two and three. But we certainly expect that to increase and ramp up. There are other products in the pipeline that -- next year, we'll be announcing that we've got new products scheduled for release in 2026. We've got a full pipeline now. We're spending $20 million a year on R&D. That will drive new product releases year after year.
Michael Legg: Great. And then just one other question. On your five-year target for '28 on those goals, historically, you've exceeded your previous long-term guidance over those time frames. With this new one, where would you say you are in comparison to making those numbers by '28 or earlier?
David Dunbar: Well, year on year, we went backwards from last year, so I'd say we maybe took a step back. The step back, as we've communicated, is largely the market. If you step back even farther, you look over 10 years, our organic growth over 10 years has been about 3% a year. Since COVID it's been 4%. With the step back this last year, just the way market cycles work, we'd expect the market to come back in the next year or so. We communicated today, we think in the second half, it will come back. So, we take that core growth of 3% over 10 years as a good proxy for our business, what it will do over the next four years. We believe our fast growth markets will still be $200 million, our sales in the fast growth markets in 2028. That leaves about $170 million of sales to come from 3% growth rate, which is about $90 million. And the new product development sales need to add about $80 million over the next four years. So, we feel very good about where we're at, given the magnitude of new products releasing now and continued progression with fast growth.
Ademir Sarcevic: Yes, and I would second that, Mike. I think we feel pretty confident and comfortable that, again, barring any unforeseen economic disruptions that we will get to those targets.
Michael Legg: Congratulations on the quarter. Thanks.
David Dunbar: Thank you, Mike.
Operator: Your next question is from the line of Chris Moore from CJS Securities. Chris. Please go ahead.
Chris Moore: Hi, good morning, guys. Thanks for taking a couple of questions.
David Dunbar: Hi, Chris. Good morning.
Chris Moore: All right. Good morning. So, it looks like you're expecting fiscal '25 to be more back half loaded. Can you maybe just talk a little bit more about the visibility surrounding the belief general markets will begin to improve? And really, are there specific segments or markets that you're thinking about? I think you talked a little bit Electronics and maybe on Engraving, but just trying to understand which segments you're thinking are really more likely second half loaded.
David Dunbar: Yes. So, I'll add a couple of data points and then Ademir can pitch in. We have some of our businesses, some segments of business, where we have good long-term visibility. So, Engineering Technologies, for example, we have a very good view in Engineering Technologies. Defense, aviation, and space especially are going to ramp up through the year. So, we feel very good, very confident about that growth. In our magnetics business, in Electronics, sales into semiconductor, manufacturing equipment, we anticipate that will start to ramp up towards the end of the calendar year. That looks really good. Another data point we have, we've talked about in past quarters, is we use the sale of switches as a leading indicator for our businesses. It's historically been a good indicator, and we've really seen that start to ramp nicely in the last few quarters. I think two quarters ago, we said we thought it bottomed out, was starting to come up. Last quarter, we said it was coming up a little bit. Now we're seeing a more decisive increase, as Ademir mentioned in his script.
Ademir Sarcevic: Yes. And Chris, if I can add to that, we also obviously track internal data, and we are encouraged by what we are seeing in video electronics over the past two months. They ran up about 30% higher in the month of June over the past six months, then July was higher. So, we are constantly optimistic that trend will continue, and we have a lot of commercial focus on making sure we gain share, and we continue to grow.
Chris Moore: Got it. I appreciate that. Conversely, are there any segments where growth is still going to be, from where you sit today, a little bit more challenging, might be flattish or up a little bit versus what we just talked about?
David Dunbar: Yes. I think we mentioned in the script, Engraving, in North America in particular, anyone following the auto OEMs in North America, they're going through, let's say, a transitional period here. Many of them have announced they're pushing out their new platforms. Ford (NYSE:F) in particular was a very good customer for us. Earlier this year, announced they're pushing platforms out by a couple of years. So we think FY '25 will be, will be a challenging year for a North American Engraving business.
Chris Moore: Got it. In terms of the longer-term goals, the organic growth, high-single digits, it seems like lots of things would have to go right in '25 in order to reach that. Is that a fair way to look at it?
David Dunbar: Well, yes, a way to think of it is. The way we think is that by the end of the year, we believe we'll be at a sequential growth rate that supports annual upper single digits. We have good visibility to this coming quarter, and we think it would start to accelerate from there based on some of the things we talked about. And by our Q3, Q4, we anticipate that growth rate will support the upper single digits. I went through the math earlier to the prior question. Of course, the markets are going to have a 3% or 4% impact on our business. But on top of that, our fast growth presence, we're very confident in the growth there. And then with the new product releases, we have a new engine for growth to take us in the upper single digits above that core.
Ademir Sarcevic: Yes. And if I can just add to that, Chris. You know half of the company is Electronics, right? And again, from what we are seeing from a macro level, Electronics had a tough year from the top line standpoint, and that's because of just the general macro environment. But we are seeing that start to improve, plus some of the new products we're going to be launching in this segment, along with their exposure to fast growth end markets, make us optimistic that as we move through the year, again, barring any unforeseen economic disruptions, that we're going to see pretty nice organic growth in the Electronics business, especially in the second half of the fiscal year. Because these orders we are taking now, it takes time for them to actually turn into sales.
Chris Moore: Got it. That's helpful. I will leave it there. I appreciate it, guys.
David Dunbar: Thank you, Chris.
Operator: Your next question is from the line of Mike Shlisky from D.A. Davidson. Mike, please go ahead.
Mike Shlisky: Good morning. Thanks for taking my questions here. So, I want to follow up on one of the earlier questions and one of your answers. I don't want to get too far ahead, but is the level of product introductions you have this fiscal year, is that supposed to be the new norm going forward? Have you unlocked a new cultural imperative to keep that product cadence fairly high?
David Dunbar: Yes. We've got good visibility to product launches this year and emerging visibility to 2026. And we see what's in the pipeline in stages zero, one, and two. I do believe this will be the new cadence for us. We'll release new products at this rate indefinitely.
Ademir Sarcevic: And Mike, if I could just add to that, we are at about 2.8% of sales in terms of R&D spend. I think we've said that we want to get over 3% as we move forward. So we're going to continue investing in R&D. We believe in these new products that are going to get launched. And as David says, watch us. See how it works out.
Mike Shlisky: Of course. Fantastic. We haven't talked much about the M&A environment yet. I'm curious if you could tell us a little bit about the pipeline, what's in the later stages, or even if you're looking to divest anything, anything is going on that process?
David Dunbar: Yes. I think we mentioned last quarter, we have a very active pipeline. The majority of the really active opportunities are privately-owned businesses. And in most cases, there's not a process. These are based on long-term relationships. So, there are some that are actionable. So, don't be surprised if in the coming months we do announce something. But until you have a deal, you don't have a deal. But I would say we feel optimistic about the environment for us. In terms of divestitures, we only have good products in our portfolio. We get inbound calls regularly about many of our businesses. And at the time of our choosing, we're confident we would have the option if we chose to divest another business. However, there's no pressing need like there was three, four years ago.
Mike Shlisky: Got it. Maybe the last one for me, back to the topic of your new products. Have any of them been released yet, just the first month into the fiscal year? And if so, how has it gone?
David Dunbar: Yes. We've got a few scheduled for release this quarter. We talked about their business, we got all the Presidents together last month and told them every quarter we're going to talk about new products. And they said, well, please don't tell our competitors what we're going to release in the coming quarter. So, wait till after the release and then update. So, in our next earnings release, we'll share the releases from this quarter and then progressively. But I have to tell you, I'm really pleased. The last three or four years, you can imagine we're spending $20 million in R&D. There was a lot of work going on. We have quarterly reviews with -- our board formed a special committee, the Innovation & Technology Committee. We review the pipeline. We review our work processes. One of our board members ran the research and development labs at Procter & Gamble. Michael Hickey on our board from Ecolab (NYSE:ECL) has a great pedigree in growth and ramping up sales of new products. So, there's been a lot of activity under the hood. So, we're really excited that FY '25, we can start to open the curtain on some of those things. And we're anxious, just as anxious as you are, to see how those new launches go. And we know that not all these new products will succeed. That's why you need a portfolio of new products. And developing new products is one thing, ramping up sales through really effective marketing and targeting and a directed commercial approach is another. So, we'll go through the year report on our progress. And it was a very exciting year for us.
Mike Shlisky: Exciting. Thanks so much. I'll pass it along.
David Dunbar: Thank you.
Ademir Sarcevic: Thanks, Mike.
Operator: Your next question is from the line of Gary Prestopino from Barrington Research. Gary, please go ahead.
Gary Prestopino: Hi. Good morning all.
David Dunbar: Hi, Gary.
Gary Prestopino: Ademir, I couldn't write this down fast enough. You talked about sequential changes in orders. Could you just go through that? I think you gave some data on June and July.
Ademir Sarcevic: Yes. Sure, Gary. So, our June orders, for the month of June, in our Electronics segment were about 30% higher than the average order rate for the past six months, May and before. And in July, that trend continued because the orders in July were another 5% higher, over 5% higher than our June orders. So, for the past two months, we've seen really positive trends from showing that the market is recovering along with some of our extended commercial activity.
Gary Prestopino: Okay. Good to hear. And then just on your new products that you're going to roll out, over a dozen new products, how many of these are targeted for your fast growth markets?
David Dunbar: Let's see. Not all of our businesses serve what we define as fast growth markets. We have a number of new products coming out in Scientific, for example. Great end market, but it's not in our fast growth. The Electronics businesses, the electronics new products, virtually all of them will have some applications, at least, in fast growth. The Engineering Technologies new products are all fast growth end markets. So, I'd roughly say half of them are fast growth.
Gary Prestopino: Okay. And then in terms of these new products, is there any -- I guess, looking for the right word here -- increase in the specialization, technology, or whatever, with these products that you should be able to attain a higher margin or contribution margin on these new products versus some of the legacy business that you have?
David Dunbar: Yes, absolutely. We anticipate that all these new products, based on the voice of customer work we've done, and our own knowledge of the product families they're part of, is that they will deliver gross margins higher than the average in that business. And some of them are just pushing the envelope of performance of the products. Some of them are entering into new adjacent segments. But our expectation -- in our funnel, when we develop a product, if it's not going to deliver higher margin, we'll pass on and prioritize those developments that will deliver higher margins.
Gary Prestopino: So, David, right off the bat, as you roll these new products out, they do have a higher incremental gross margin, and we should see positive impact to the gross margin as we go through the year.
David Dunbar: Yes, that's our expectation. We've got limited experience. Over the last five years, we've launched a handful of products. Those new products are selling at higher margins. So, based on that experience and our voice of customer development, we do believe that, at moment of launch, they will be accretive to our margins.
Gary Prestopino: Okay. Thank you very much.
David Dunbar: Thank you.
Operator: [Operator Instructions] Your next question comes from the line of Ross Sparenblek from William Blair. Ross, please go ahead.
Ross Sparenblek: Hi, good morning, gentlemen.
David Dunbar: Good morning, Ross.
Ademir Sarcevic: Good morning, Ross.
Ross Sparenblek: Hi. To start on the new products, it was a curious comment that you don't expect all these are going to succeed, even though the vast majority are voice of the customer. I believe 70% are educated there, so is there still a way to think about it? Maybe 30% of the dozen are just throwing it out there to see what sticks?
David Dunbar: Well, look, everybody, when they launch a product believes it's going to succeed. The reality is, if you look at the data, not all new products succeed. In fact, most of them fall short of expectations. That's why you need a portfolio of them. Some will far exceed the expectation. So, I think we're just looking at others' experience to say, let's be honest and humble here, they're not all going to succeed. But we think we have enough of them and enough of them will succeed enough and probably exceed our expectations to drive our top line growth. So, I didn't mean to confuse you with that statement. We're not going to launch something knowing that it's not going to succeed, but we're just learning from experience here.
Ross Sparenblek: Okay. Maybe I'm just reading too much into it, but thanks for the clarity there. And then maybe just framing the average TAM expectations. A dozen products, $7 million in sales, they're not all going to hit July 1st, obviously. But what are you guys targeting? And then what is maybe like your ROI or product vitality index threshold as we think about conceptualizing that ramp and how these can build if they are successful?
David Dunbar: Well, those are great questions. I think in the course of the year, we will get better and better about talking about those things. I would say that our sales this last year of the products that have been released in the last five years, something like mid-single digit percent of our sales. We think that will go up another 100 basis points or more this coming year. Over five plus years -- we'll see how long it takes these to ramp, but for us to -- you could create your own model here, but for us to deliver upper-single-digit growth long-term and relying on new products to some extent, we're going to have to get into the teens and above over time with new products. I don't know when we'll get there. As we evolve, we'll share that more. Ademir, do you have something to add?
Ademir Sarcevic: No, I think that's right. That's right.
Ross Sparenblek: Okay. Is there anything you can call out particularly like, hey, this is a $20 million opportunity, and we're really excited, and the other ones are just taking a little adjacent share here and there?
David Dunbar: I think what we do is quarter by quarter as we announce what's been released, we would do that. We do have some that potentially really expand our served market and have a $20 million-plus opportunity.
Ademir Sarcevic: But Ross, just to put it in perspective, we wouldn't launch a product and say it's a $2 million market opportunity. We are talking about much higher opportunity we are targeting. So these are significant changes.
Ross Sparenblek: Yes, that's right. Last one here on just Electronics margins and expectations. I know we have 200 basis points of prior cost out. I think there's like five magnetic products that are launching, which are dilutive. So, how should we think about the incrementals this year given the cross-currents and then what level of revenue do you think we need to achieve for Electronics to get back to the 2023 22%, 23%?
Ademir Sarcevic: Yes, I think, Ross, you're going to get a few things working in our favor. Obviously, the volume, that margin pull-through that you get from a higher volume, we are still getting some price and productivity. We've got new products that are going to be launched, and we would expect our margin in Electronics to improve sequentially as we move through the fiscal year. And we do believe the second half will be stronger from a revenue standpoint than the first half. So, again, as David said, you can do your own model, but as you think about the second half of FY '25, we are optimistic that the margin is going to get better than it is today.
Ross Sparenblek: All right. Thanks, guys.
David Dunbar: Thank you.
Operator: [Operator Instructions] There are no further questions at this time. I'll hand the call over to David Dunbar for closing remarks. Sir, please go ahead.
David Dunbar: All right. Thank you. I want to thank everybody for joining us on the call. We enjoy reporting on our progress at Standex. And finally, again, I want to thank our employees and shareholders for your continued support and contributions. We look forward to speaking with you again in our fiscal first quarter 2025 call.
Operator: Ladies and gentlemen, this concludes today's conference. Thank you very much for your participation. You may now disconnect.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.